15 results
8-K
EX-99.1
CADL
Candel Therapeutics Inc
6 Jun 22
Regulation FD Disclosure
8:37am
Medicine, and Director of the Multidisciplinary Pulmonary Oncology Program at NYU Langone Health Conflict of interest disclosure: Nothing to disclose 15 … of Medical Oncology at the Yale Cancer Center and Smilow Cancer Hospital Conflict of interest disclosure: Member of Candel’s Research Advisory Board
S-1/A
EX-10.6
CADL
Candel Therapeutics Inc
16 Jul 21
IPO registration (amended)
6:07am
not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either … ) Indemnitee shall have reasonably concluded that there may be a conflict of interest between the Company and Indemnitee in the conduct of such defense, (C
S-1/A
EX-10.5.5
CADL
Candel Therapeutics Inc
16 Jul 21
IPO registration (amended)
6:07am
month on average), and (iii) serve on boards of directors of companies that are not competitive with the Company, do not otherwise present a conflict … of interest and would not otherwise interfere with Executive’s responsibilities and the performance of Executive’s duties hereunder, subject
S-1/A
EX-10.5.4
CADL
Candel Therapeutics Inc
16 Jul 21
IPO registration (amended)
6:07am
with the Executive’s performance of the Executive’s duties to the Company and do not otherwise present a conflict of interest, the Executive may (i) engage
S-1/A
EX-10.5.3
CADL
Candel Therapeutics Inc
16 Jul 21
IPO registration (amended)
6:07am
on boards of directors of companies that are not competitive with the Company, do not otherwise present a conflict of interest and would not otherwise
S-1/A
EX-10.5.2
ofs7ei zed
16 Jul 21
IPO registration (amended)
6:07am
10-K
EX-10.12
xgxnz6jobwyal0jvido
29 Mar 22
Annual report
8:46am
DEF 14A
sko6i32 cydham274
2 Sep 22
Definitive proxy
8:30am
S-1
EX-4.2
relbtuj12ulb8
25 Jun 21
IPO registration
5:28pm
S-1/A
iertwt0z1goy
16 Jul 21
IPO registration (amended)
6:07am
424B4
d02z fgxh
28 Jul 21
Prospectus supplement with pricing info
4:02pm
S-1
v5uo1xa9eln
25 Jun 21
IPO registration
5:28pm
DRS/A
esdq7
31 Mar 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next